National Cancer Institute; Notice of Closed Meetings, 23474 [2018-10677]
Download as PDF
<![CDATA[
23474
Federal Register / Vol. 83, No. 98 / Monday, May 21, 2018 / Notices
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: May 15, 2018.
Michelle D. Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–10680 Filed 5–18–18; 8:45 am]
BILLING CODE 4140–01–P
Center, Room 3W302, Bethesda, MD 20892–
9750, 240–276–5664, tondravim@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: May 15, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
[FR Doc. 2018–10677 Filed 5–18–18; 8:45 am]
BILLING CODE 4140–01–P
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Cancer Institute, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
sradovich on DSK3GMQ082PROD with NOTICES
National Cancer Institute; Notice of
Closed Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Name of Committee: Board of Scientific
Counselors for Clinical Sciences and
Epidemiology National Cancer Institute.
Date: July 9, 2018.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health, 31
Center Drive, Building 31, Wing C; 6th Floor,
Conference Room 6, Bethesda, MD 20892.
Contact Person: Brian E. Wojcik, Ph.D.,
Senior Review Administrator, Institute
Review Office, Office of the Director,
National Cancer Institute, National Institutes
of Health, 9609 Medical Center, Room
3W414, Bethesda, MD 20892–9750, 240–276–
5664, wojcikb@mail.nih.gov.
Name of Committee: Board of Scientific
Counselors for Basic Sciences National
Cancer Institute.
Date: July 10, 2018.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health, 31
Center Drive, Building 31, Wing C; 6th Floor,
Conference Room 6, Bethesda, MD 20892.
Contact Person: Mehrdad M. Tondravi,
Ph.D., Chief, Institute Review Office, Office
of the Director, National Cancer Institute,
National Institutes of Health, 9609 Medical
VerDate Sep<11>2014
18:20 May 18, 2018
Jkt 244001
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Reproduction, Andrology,
and Gynecology Subcommittee.
Date: June 23, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Dennis E. Leszczynski,
Ph.D., Scientific Review Administrator,
Division of Scientific Review, National
Institute of Child Health and Human
Development, NIH, 6100 Executive
Boulevard, Room 5B01, Bethesda, MD 20892,
(301) 435–2717, leszczyd@mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; The Role of Stem/
Progenitor Cells in the Pathogenesis and
Treatment of Gynecologic Disorders.
Date: June 18, 2018.
Time: 8:00 a.m. to 12:00 p.m.
PO 00000
Frm 00061
Fmt 4703
Sfmt 9990
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Dennis E. Leszczynski,
Ph.D., Scientific Review Administrator,
Division of Scientific Review, National
Institute of Child Health and Human
Development, NIH, 6100 Exeuctive Blvd.,
Rm. 5B01 Bethesda, MD 20892, (301) 435–
6884, leszczyd@mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Obstetrics and Maternal-Fetal
Biology Subcommittee.
Date: June 22, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Peter Zelazowski, Ph.D.,
Scientific Review Officer, National Institutes
of Health, NICHD, SRB, 6710B Rockledge
Drive, Bethesda, MD 20892, 301–435–6902,
peter.zelazowski@nih.gov.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Health, Behavior, and Context
Subcommittee.
Date: June 25, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Kimberly L. Houston, MD,
Scientific Review Officer, Eunice Kennedy
Shriver National Institute of Children Health
and Human Development, 6701B Rockledge
Drive, Room 2127B, Bethesda, MD 20892,
301–827–4902, kimberly.houston@nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Reproductive
Scientist Development Program (RSDP).
Date: June 29, 2018.
Time: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Dennis E. Leszczynski,
Ph.D., Scientific Review Administratorl
Division of Scientific Review, National
Institute of Child Health and Human
Development, NIH, 6100 Exeuctive Blvd.,
Rm. 5B01, Bethesda, MD 20892, (301) 435–
6884, leszczyd@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: May 15, 2018.
Michelle D. Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–10681 Filed 5–18–18; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\21MYN1.SGM
21MYN1
]]>Agencies
[Federal Register Volume 83, Number 98 (Monday, May 21, 2018)]
[Notices]
[Page 23474]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-10677]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Cancer Institute, including consideration of personnel qualifications
and performance, and the competence of individual investigators, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Board of Scientific Counselors for Clinical
Sciences and Epidemiology National Cancer Institute.
Date: July 9, 2018.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, 31 Center Drive, Building
31, Wing C; 6th Floor, Conference Room 6, Bethesda, MD 20892.
Contact Person: Brian E. Wojcik, Ph.D., Senior Review
Administrator, Institute Review Office, Office of the Director,
National Cancer Institute, National Institutes of Health, 9609
Medical Center, Room 3W414, Bethesda, MD 20892-9750, 240-276-5664,
[email protected].
Name of Committee: Board of Scientific Counselors for Basic
Sciences National Cancer Institute.
Date: July 10, 2018.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, 31 Center Drive, Building
31, Wing C; 6th Floor, Conference Room 6, Bethesda, MD 20892.
Contact Person: Mehrdad M. Tondravi, Ph.D., Chief, Institute
Review Office, Office of the Director, National Cancer Institute,
National Institutes of Health, 9609 Medical Center, Room 3W302,
Bethesda, MD 20892-9750, 240-276-5664, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: May 15, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-10677 Filed 5-18-18; 8:45 am]
BILLING CODE 4140-01-P
